Page last updated: 2024-09-03

cercosporamide and Neoplasm Metastasis

cercosporamide has been researched along with Neoplasm Metastasis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dowless, MS; Dumstorf, CA; Ellis, KE; Furic, L; Graff, JR; Iversen, PW; Konicek, BW; McCann, DJ; McNulty, AM; Parsons, S; Peery, RB; Pelletier, J; Robichaud, N; Sonenberg, N; Stancato, LF; Stephens, JR; Yingling, JM1

Other Studies

1 other study(ies) available for cercosporamide and Neoplasm Metastasis

ArticleYear
Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.
    Cancer research, 2011, Mar-01, Volume: 71, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Base Sequence; Benzofurans; Blotting, Western; Cell Proliferation; Eukaryotic Initiation Factor-4E; Female; Humans; Inhibitory Concentration 50; Intracellular Signaling Peptides and Proteins; Lung Neoplasms; Mice; Mice, Nude; Molecular Sequence Data; Neoplasm Metastasis; Phosphorylation; Polymerase Chain Reaction; Protein Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2011